Skip to main content

major depressive disorder Archives

Noninvasive treatment for refractory OCD, major depression shows promise for lifelong benefits

Oct. 15, 2020—Four months ago, a multidisciplinary care team at Vanderbilt University Medical Center treated a patient with lifelong major depressive disorder (MDD) and obsessive compulsive disorder (OCD) — conditions that left her debilitated with intrusive thoughts, constant fear, suicidal intent and anorexia.

Read more


Treatment resistance of mental disorders studied

Mar. 28, 2019—With the aid of a four-year, $3.4 million grant from the National Institute of Mental Health, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital (MGH) will apply new techniques to investigate treatment resistance of two devastating mental disorders — major depressive disorder, which befalls 15 percent of people at some point in their lives, and schizophrenia, which affects approximately 1 percent.

Read more


Cytokine-cognition connection

Oct. 1, 2018—Targeting the immune system may provide a new avenue for therapeutic intervention in psychiatric diseases characterized by motivational and cognitive deficits.

Read more


Depression poses heart risk for HIV patients: study

Oct. 8, 2015—The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more